Sunday 11 October 2026
Export all DOC data to Excel Powerpack
Healthpeak Properties, Inc.
DOC Real Estate Reit Healthcare Facilities
Healthpeak Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.8 billion, up 4.52% from fiscal 2024. In the quarter to June 2026, revenue grew 11.1%, EPS grew 60.0%, free cash flow fell 30.5% and total debt rose 11.0%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for five consecutive years, operating cash flow growth for five.
18.80
0.28
+1.51%
Follow DOC
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
61.14 | 51.34 | 160.80 | 0.00 |
+8 more quarters Free account |
P/S ratio |
5.00 | 3.98 | 3.97 | 4.75 | |
P/FCF ratio |
0.00 | 255.36 | 32.98 | 26.12 | |
P/Operating CF |
40.88 | 43.78 | 38.06 | 42.25 | |
P/B ratio |
1.56 | 1.26 | 1.37 | 1.62 | |
Price to Tangible BV |
1.70 | 1.39 | 1.51 | 1.74 | |
EV/Sales |
7.82 | 7.16 | 7.26 | 7.95 | |
EV/EBITDA |
15.57 | 14.13 | 13.90 | 15.32 | |
EV/Operating CF |
18.75 | 16.68 | 16.38 | 17.95 | |
EV/FCF |
(1,193.91) | 460.09 | 60.42 | 43.74 | |
Quick Ratio |
2.64 | 2.02 | 0.86 | 0.32 | |
Current Ratio |
3.02 | 2.96 | 1.70 | 1.22 | |
Net Debt/EBITDA |
21.70 | 25.64 | 24.89 | 24.42 | |
Debt/Assets |
46.27% | 48.22% | 48.43% | 46.63% | |
Debt/Equity |
1.06 | 1.15 | 1.21 | 1.11 | |
Asset Turnover |
0.14 | 0.14 | 0.14 | 0.14 | |
Operating CF/Net income |
6.86 | 1.35 | 2.58 | (2.69) | |
Capex/Depreciation |
(0.83) | (1.81) | (1.50) | (0.85) | |
Interest Coverage |
1.35 | 1.06 | 1.73 | 1.68 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
2.92% | 3.27% | 3.28% | 2.82% | |
Intangible Assets out of Total Assets |
0.04 | 0.04 | 0.04 | 0.03 | |
Share Based Compensation of Revenue |
0.62% | 1.24% | 0.56% | 0.57% | |
Graham Net Nets |
(0.69) | (0.93) | (0.98) | (0.78) | |
Graham Number |
10.40 | 9.67 | 5.13 | 0.00 | |
Earnings Yield |
1.64% | 1.95% | 0.62% | (0.26%) | |
Free Cash Flow Yield |
(0.13%) | 0.39% | 3.03% | 3.83% | |
Revenue per Share |
1.12 | 1.08 | 1.03 | 1.02 | |
Operating CF per Share |
0.52 | 0.38 | 0.42 | 0.45 | |
Capex per Share |
(0.31) | (0.69) | (0.51) | (0.29) | |
Free Cash Flow per Share |
0.21 | (0.31) | (0.08) | 0.16 | |
Cash per Share |
2.49 | 1.82 | 0.77 | 0.23 | |
Shareholders Equity per Share |
13.73 | 12.99 | 11.70 | 11.85 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
13.73 | 12.99 | 11.70 | 11.85 | |
Free Cash Flow |
146.19 | (218.74) | (58.42) | 111.65 | |
Working Capital |
1,373.53 | 1,317.78 | 503.54 | 167.85 | |
Capital Expenditures |
(214.91) | (479.62) | (352.51) | (203.31) | |
Net Current Asset Value |
(10,157.08) | (10,594.41) | (10,971.10) | (10,430.83) | |
EV/EBIT |
47.45 | 42.94 | 39.47 | 46.36 | |
Capex to Sales |
0.28 | 0.64 | 0.49 | 0.29 | |
Price to Operating Income |
30.35 | 23.83 | 21.54 | 27.69 | |
| Other line items | |||||
Average Receivables |
70.44 | 80.19 | 77.57 | 72.91 | |
Average Payables |
708.65 | 670.73 | 721.93 | 748.06 | |
Average Assets |
20,745.16 | 20,715.98 | 20,137.14 | 19,776.09 | |
Average Common Equity |
9,018.79 | 8,930.90 | 8,598.94 | 8,729.09 |
Columns are period end dates